TABLE 2.
Parameter value | SE | 95% lower CI | 95% upper CI | t | P | Partial η2 | |
---|---|---|---|---|---|---|---|
1. Pre–post for SER | 1.64 | 4.46 | –7.51 | 10.80 | 0.37 | .72 | .01 |
2. Pre–post for PE | 15.96 | 2.69 | 10.44 | 21.48 | 5.93 | <.001 | .57 |
3. Pre-FU for SER | 7.20 | 5.19 | –3.44 | 17.85 | 1.39 | .18 | .07 |
4. Pre-FU for PE | 17.02 | 3.13 | 10.61 | 23.44 | 5.44 | <.001 | .52 |
5. IC1: Pre, Post by SER, PE | –14.32 | 5.21 | –25.01 | –3.63 | 2.75 | .01 | .22 |
6. IC2: Pre, FU by SER, PE | –9.82 | 6.06 | –22.25 | 2.61 | 1.62 | .12 | .09 |
Note: Pre, pretreatment; post, immediate post-treatment; FU, last available follow-up; SER, sertraline; PE, prolonged exposure; CI, confidence interval; IC, interaction contrast. All analyses are based on adjusted means using propensity scores and do not reflect raw mean changes.